Behl T, Kaur I, Sehgal A et al (2021) The footprint of kynurenine pathway in neurodegeneration: janus-faced role in Parkinson’s disorder and therapeutic implications. Int J Mol Sci 22:6737. https://doi.org/10.3390/ijms22136737

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. Lancet 397:2284–2303. https://doi.org/10.1016/S0140-6736(21)00218-X

Article  CAS  PubMed  Google Scholar 

Bondulich MK, Fan Y, Song Y et al (2021) Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease. Sci Rep 11:5484. https://doi.org/10.1038/s41598-021-84858-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borkowski LF, Craig TA, Stricklin OE et al (2020) 5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A). Respir Physiol Neurobiol 279:103471. https://doi.org/10.1016/j.resp.2020.103471

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braidy N, Grant R, Brew BJ et al (2009) Effects of kynurenine pathway metabolites on intracellular NAD synthesis and cell death in human primary astrocytes and neurons. Int J Tryptophan Res 2:61–69. https://doi.org/10.4137/ijtr.s2318

Article  CAS  PubMed  PubMed Central  Google Scholar 

Connor TJ, Starr N, O’Sullivan JB, Harkin A (2008) Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-γ? Neurosci Lett 441:29–34. https://doi.org/10.1016/j.neulet.2008.06.007

Article  CAS  PubMed  Google Scholar 

Cortés Malagón EM, López Ornelas A, Olvera Gómez I, Bonilla Delgado J (2024) The kynurenine pathway, aryl hydrocarbon receptor, and Alzheimer’s disease. Brain Sci 14:950. https://doi.org/10.3390/brainsci14090950

Article  CAS  PubMed  PubMed Central  Google Scholar 

den Eynde VV, Abdelmoemin WR, Abraham MM et al (2023) The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectr 28:427–440. https://doi.org/10.1017/S1092852922000906

Article  PubMed  Google Scholar 

Fathi M, Vakili K, Yaghoobpoor S et al (2022) Dynamic changes in metabolites of the kynurenine pathway in Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease: a systematic review and meta-analysis. Front Immunol 13:997240. https://doi.org/10.3389/fimmu.2022.997240

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong X, Chang R, Zou J et al (2023) The role and mechanism of tryptophan - kynurenine metabolic pathway in depression. Rev Neurosci 34:313–324. https://doi.org/10.1515/revneuro-2022-0047

Article  CAS  PubMed  Google Scholar 

González-Cota AL, Martínez-Flores D, Rosendo-Pineda MJ, Vaca L (2024) NMDA receptor-mediated Ca2 + signaling: impact on cell cycle regulation and the development of neurodegenerative diseases and cancer. Cell Calcium 119:102856. https://doi.org/10.1016/j.ceca.2024.102856

Article  CAS  PubMed  Google Scholar 

Grégoire L, Rassoulpour A, Guidetti P et al (2008) Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys. Behav Brain Res 186:161–167. https://doi.org/10.1016/j.bbr.2007.08.007

Article  CAS  PubMed  Google Scholar 

Hernandez SM, Tikhonova EB, Karamyshev AL (2020) Protein-Protein interactions in alpha-synuclein biogenesis: new potential targets in Parkinson’s disease. Front Aging Neurosci 12:72. https://doi.org/10.3389/fnagi.2020.00072

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hestad K, Alexander J, Rootwelt H, Aaseth JO (2022) The role of tryptophan dysmetabolism and quinolinic acid in depressive and neurodegenerative diseases. Biomolecules 12:998. https://doi.org/10.3390/biom12070998

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heylen A, Vermeiren Y, Kema IP et al (2023) Brain kynurenine pathway metabolite levels may reflect extent of neuroinflammation in ALS, FTD and early onset AD. Pharmaceuticals (Basel) 16:615. https://doi.org/10.3390/ph16040615

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang X, Yang K, Zhang Y et al (2016) Quinolinic acid induces cell apoptosis in PC12 cells through HIF-1-dependent RTP801 activation. Metab Brain Dis 31:435–444. https://doi.org/10.1007/s11011-015-9782-x

Article  CAS  PubMed  Google Scholar 

Hunt C, Macedo e Cordeiro T, Suchting R et al (2020) Effect of immune activation on the kynurenine pathway and depression symptoms – a systematic review and meta-analysis. Neurosci Biobehav Rev 118:514–523. https://doi.org/10.1016/j.neubiorev.2020.08.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jamwal S, Singh S, Kaur N, Kumar P (2015) Protective effect of spermidine against excitotoxic neuronal death induced by quinolinic acid in rats: possible neurotransmitters and neuroinflammatory mechanism. Neurotox Res 28:171–184. https://doi.org/10.1007/s12640-015-9535-y

Article  CAS  PubMed  Google Scholar 

Jauhari A, Baranov SV, Suofu Y et al (2020) Melatonin inhibits cytosolic mitochondrial DNA–induced neuroinflammatory signaling in accelerated aging and neurodegeneration. J Clin Invest 130:3124–3136. https://doi.org/10.1172/JCI135026

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jee HJ, Lee SG, Bormate KJ, Jung Y-S (2020) Effect of caffeine consumption on the risk for neurological and psychiatric disorders: sex differences in human. Nutrients 12:3080. https://doi.org/10.3390/nu12103080

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joisten N, Ruas JL, Braidy N et al (2021) The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force? Trends Mol Med 27:946–954. https://doi.org/10.1016/j.molmed.2021.07.006

Article  CAS  PubMed  Google Scholar 

Kaur H, Bose C, Mande SS (2019) Tryptophan metabolism by gut microbiome and gut-brain-axis: an in silico analysis. Front Neurosci 13:1365. https://doi.org/10.3389/fnins.2019.01365

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Li W, Wang J et al (2023) Biosynthesis of neuroprotective melatonin is dysregulated in Huntington’s disease. J Pineal Res 75:e12909. https://doi.org/10.1111/jpi.12909

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J (2021) Chemical update on the potential for serotonin 5-HT6 and 5-HT7 receptor agents in the treatment of Alzheimer’s disease. Bioorg Med Chem Lett 49:128275. https://doi.org/10.1016/j.bmcl.2021.128275

Article  CAS  PubMed  Google Scholar 

Li S, Cai Y, Guan T et al (2024) Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites. Gut Microbes 16:2374608. https://doi.org/10.1080/19490976.2024.2374608

Article  CAS  PubMed  PubMed Central  Google Scholar 

Loh JS, Mak WQ, Tan LKS et al (2024) Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 9:37. https://doi.org/10.1038/s41392-024-01743-1

Article  PubMed  PubMed Central